Today: 2 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Johnson & Johnson stock: Talc-court twist and EU drug nod set up next week

Johnson & Johnson stock: Talc-court twist and EU drug nod set up next week

New York, January 31, 2026, 10:29 EST — The market has closed. Johnson & Johnson shares edged down 3 cents to $227.25 on Friday after a U.S. judge dismissed a lawsuit accusing the company of fraud related to its talc bankruptcy approach. The plaintiffs claimed J&J employed a “Texas two-step,” moving talc liabilities into a subsidiary that filed for bankruptcy to stall cancer lawsuits. Judge Michael Shipp ruled they hadn’t proven any real harm caused by the delay. J&J’s litigation head Erik Haas slammed the claims as “wholly meritless,” while the plaintiffs’ attorney said they’re considering an appeal.
31 January 2026
··
Eli Lilly stock price (LLY): $3.5B plant, EU Mounjaro call and earnings ahead — what to watch

Eli Lilly stock price (LLY): $3.5B plant, EU Mounjaro call and earnings ahead — what to watch

New York, Jan 31, 2026, 09:59 EST — The market has closed. Shares of Eli Lilly finished Friday up about 1.3%, closing at $1,037.15. The boost came after the company unveiled a $3.5 billion plan for a new manufacturing facility in Pennsylvania. This plant will produce injectable weight-loss drugs, including retatrutide—a next-gen medication Lilly says has outperformed Zepbound. “All these sites, including this one, will be really state of the art manufacturing to last many decades to come,” CEO David Ricks said in Allentown. Drugmakers like Pfizer and Merck & Co are also expanding U.S. capacity amid Donald Trump’s threat of import tariffs. Meanwhile, Lilly is racing Novo Nordisk for U.S. approval of an oral weight-loss pill, which it plans to price at $150 a month and launch in several countries.
31 January 2026
···
Tesla stock price jumps on SpaceX-xAI merger talk — what TSLA investors watch next week

Tesla stock price jumps on SpaceX-xAI merger talk — what TSLA investors watch next week

New York, January 31, 2026, 09:43 EST — Market closed Tesla shares rose 3.3% on Friday to $430.41. The move followed reports of merger talks involving SpaceX and Elon Musk’s AI startup xAI, along with chatter about a possible tie-up between Tesla and the rocket-and-satellite company. “A single entity would help to further align his attention and ample resources to one company,” said Andrew Rocco, stock strategist at Zacks Investment Research.
31 January 2026
··
1 … 334 335 336 337 338 … 877

Stock Market Today

  • COMP Options See Heavy Action as Implied Volatility Spikes
    July 2, 2026, 2:05 PM EDT. Compass Inc (COMP) options drew attention today with the July 17, 2026 $2 call posting some of the highest implied volatility in the market. This signals traders are pricing in bigger price swings for the stock. Even so, analysts are holding back-COMP has a Zacks Rank #3 (Hold), and earnings consensus for the quarter fell from 21 cents to 9 cents per share in the last 60 days. The split between cautious analysts and active options traders suggests some are leaning into volatility to collect premium, betting the stock won't move as much as the options market is showing.
Go toTop